Biomedicine Hub (May 2024)

Impact of Selective Reporting of Antibiotic Susceptibility Test Results on Antibiotic Use in Patients with Bloodstream Infection with Streptococcus pneumoniae

  • Florian Geismann,
  • Kathleen Brueckner,
  • Michael Pfeifer,
  • Bernd Salzberger,
  • Stilla Bauernfeind,
  • Florian Hitzenbichler,
  • Michaela Simon,
  • Aila Caplunik-Pratsch,
  • Wulf Schneider-Brachert,
  • Clemens Wiest,
  • Thilo Hinterberger,
  • Tamara Ruegamer,
  • Arno Mohr

DOI
https://doi.org/10.1159/000537770
Journal volume & issue
Vol. 9, no. 1
pp. 67 – 72

Abstract

Read online

Introduction: Invasive pneumococcal disease is a major cause of morbidity and mortality in infectious diseases. Selective reporting of antibiotic susceptibility test results might lead to a tailored antibiotic therapy and could therefore be an important antibiotic stewardship program intervention. The aim of this study was to analyse whether a switch to selective reporting of antibiotic test results leads to a more focused antibiotic therapy in patients with a bloodstream infection with Streptococcus pneumoniae. Methods: This study was performed as a retrospective cohort study at the University Hospital Regensburg, Germany. All blood cultures positive for Streptococcus pneumoniae between 2006 and 2021 were analysed. In 2014, a switch to selective reporting of antibiotic susceptibility test results omitting sensitivity results for agents not recommended was introduced. Results: Twenty-four hours after final antibiotic susceptibility test results were available, 20.9% before (BI) versus 15.4% after implementation (AI) of selective reporting of antibiotic test results received a narrow-spectrum penicillin, while only 2.3% BI versus 5.8% AI received a narrow-spectrum penicillin from the beginning. Conclusion: Selective reporting of antibiotic susceptibility test results without further antimicrobial stewardship interventions did not lead to a higher use of a narrow-spectrum penicillin in this study.

Keywords